Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 1 30Phase 1/2 10Phase NA 5Phase 4 3Phase 3 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 110Genitourinary 98Gastrointestinal 81Breast 76Lymphoid 61Other hematologic neoplasm 41Gynecologic 37Plasma cell 32Head & Neck 32Sarcoma 17CNS 17Dermatologic 12Endocrine 9NET 5Tumor-Agnostic 4Other solid neoplasm 4Myeloid 3Classical hematology 2

Conditions

Polycythemia Vera 1Philadelphia Chromosome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Anemia 1

Interventions

nilotinib 1asciminib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Myeloid × 30 days × Clear all
NCT05456191 2026-05-27

ASC4START

Novartis

Phase 3 Active not recruiting
568 enrolled 11 charts
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06499285 2026-05-13

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Takeda

Phase 3 Recruiting
225 enrolled
Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

NCT07429266 2026-05-08

A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Ono Pharmaceutical Co., Ltd.

Phase 3 Recruiting
250 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡